Analysts’ Price Target Changes for January, 4th (ABEO, ACER, APEN, BAYN, BOLD, CASY, CHD, CLX, DMPI, DPS)

Analysts’ price target changes for Thursday, January 4th:

Abeona Therapeutics (NASDAQ:ABEO) was given a $30.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Opexa Therapeutics (NASDAQ:ACER) was given a $50.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Apollo Endosurgery (NASDAQ:APEN) was given a $10.00 target price by analysts at Roth Capital. The firm currently has a buy rating on the stock.

Bayer (FRA:BAYN) was given a €131.00 ($155.95) target price by analysts at Sanford C. Bernstein. The firm currently has a buy rating on the stock.

Audentes Therapeutics (NASDAQ:BOLD) was given a $37.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Casey's General Stores (NASDAQ:CASY) had its target price boosted by Wells Fargo & Co from $105.00 to $118.00. Wells Fargo & Co currently has a market perform rating on the stock.

Church & Dwight (NYSE:CHD) had its target price increased by Wells Fargo & Co from $47.00 to $52.00. The firm currently has a market perform rating on the stock.

Clorox (NYSE:CLX) had its price target raised by Wells Fargo & Co from $130.00 to $146.00. Wells Fargo & Co currently has a market perform rating on the stock.

DelMar Pharmaceuticals (NASDAQ:DMPI) was given a $12.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Dr Pepper Snapple Group (NYSE:DPS) had its price target boosted by Wells Fargo & Co from $98.00 to $112.00. Wells Fargo & Co currently has an outperform rating on the stock.

Estee Lauder Companies (NYSE:EL) had its price target raised by Wells Fargo & Co from $135.00 to $145.00. They currently have an outperform rating on the stock.

FedEx (NYSE:FDX) had its price target boosted by Loop Capital to $318.00.

Five Below (NASDAQ:FIVE) had its target price increased by MKM Partners to $75.00. MKM Partners currently has a buy rating on the stock.

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) was given a €90.00 ($107.14) target price by analysts at Independent Research GmbH. The firm currently has a neutral rating on the stock.

Fresenius SE & Co KGaA (FRA:FRE) was given a €80.00 ($95.24) target price by analysts at Independent Research GmbH. The firm currently has a buy rating on the stock.

Galectin Therapeutics (NASDAQ:GALT) had its price target boosted by Roth Capital from $3.00 to $8.00. The firm currently has a buy rating on the stock.

Illumina (NASDAQ:ILMN) had its target price boosted by Piper Jaffray Companies to $274.00. They currently have an overweight rating on the stock.

Intuit (NASDAQ:INTU) had its price target raised by JPMorgan Chase & Co. to $163.00. They currently have a neutral rating on the stock.

Kohl's (NYSE:KSS) was given a $48.00 price target by analysts at MKM Partners. The firm currently has a hold rating on the stock.

Lululemon Athletica (NASDAQ:LULU) had its price target reduced by Deutsche Bank AG from $95.00 to $89.00. Deutsche Bank AG currently has a neutral rating on the stock.

Monster Beverage (NASDAQ:MNST) had its target price boosted by Wells Fargo & Co from $54.00 to $60.00. Wells Fargo & Co currently has a market perform rating on the stock.

Altria Group (NYSE:MO) had its target price raised by Wells Fargo & Co from $80.00 to $85.00. Wells Fargo & Co currently has an outperform rating on the stock.

Murphy USA (NYSE:MUSA) had its target price boosted by Wells Fargo & Co. Wells Fargo & Co currently has a market perform rating on the stock.

Neogen (NASDAQ:NEOG) was given a $62.00 price target by analysts at Roth Capital. The firm currently has a hold rating on the stock.

ObsEva (NASDAQ:OBSV) was given a $25.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Omeros (NASDAQ:OMER) was given a $30.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Spark Therapeutics (NASDAQ:ONCE) had its target price raised by SunTrust Banks, Inc. to $113.00. They currently have a buy rating on the stock.

Pepsico (NASDAQ:PEP) had its target price boosted by Wells Fargo & Co from $110.00 to $115.00. The firm currently has a market perform rating on the stock.

Parker-Hannifin (NYSE:PH) had its target price raised by BMO Capital Markets to $225.00. They currently have an outperform rating on the stock.

Protalix Biotherapeutics (NYSEAMERICAN:PLX) was given a $5.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Resonant (NASDAQ:RESN) was given a $8.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Stifel Financial (NYSE:SF) had its target price boosted by Wells Fargo & Co from $64.00 to $70.00.

J M Smucker (NYSE:SJM) was given a $128.00 target price by analysts at Wells Fargo & Co. The firm currently has a hold rating on the stock.

Spectrum Brands (NYSE:SPB) had its target price boosted by Wells Fargo & Co from $125.00 to $132.00. They currently have an outperform rating on the stock.

Constellation Brands (NYSE:STZ) had its target price boosted by Wells Fargo & Co from $235.00 to $260.00. The firm currently has an outperform rating on the stock.

Atlassian (NASDAQ:TEAM) had its price target raised by Oppenheimer Holdings Inc.. The firm currently has an outperform rating on the stock.

Treehouse Foods (NYSE:THS) was given a $46.00 target price by analysts at Wells Fargo & Co. The firm currently has a hold rating on the stock.

Vantiv (NYSE:VNTV) had its target price boosted by SunTrust Banks, Inc. from $69.00 to $77.00. The firm currently has a hold rating on the stock.

Vodafone Group (LON:VOD) was given a GBX 285 ($3.81) price target by analysts at UBS Group AG. The firm currently has a buy rating on the stock.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target boosted by Oppenheimer Holdings Inc. from $175.00 to $190.00. They currently have an outperform rating on the stock.

Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply